
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1492494
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To investigate the value of preoperative prediction of risk factors for recurrence of operable cervical cancer based on the radiomic features of biparametric magnetic resonance imaging (bp-MRI) combined with clinical features. Method: Retrospective collection of cervical cancer cases undergoing radical hysterectomy + pelvic and/or para-aortic lymph node dissection at the Affiliated Hospital of North Sichuan Medical College. Region of interest (ROI) was outlined using 3D slicer software, and radiomics after feature extraction and feature screening using the least absolute shrinkage and selection operator (LASSO) algorithm. Logistic regression algorithms were used to construct a fusion clinical-radiomics model to visualize with Nomogram. Receiver operating characteristic (ROC), DeLong test, calibration curve (CC) and decision curve (DC) were used to evaluate the predictive performance and clinical benefit of the model. Result: A total of 99 patients with cervical cancer were included in this study, with 79 and 20 cases in the train and test groups. Seventeen key features were selected for radiomics model construction. Three clinical features were screened to construct a clinical model. A fusion model of the radiomics model combined with the clinical model was constructed.The area under curve (AUC) in the train group was 0.710 (95%CI 0.602-0.819), 0.892 (95% CI 0.826-0.958), 0.906 (95% CI 0.842-0.970), for the comparative clinical model, radiomics model and fusion model, respectively, and the AUC in the test group were 0.620(95% CI 0.366-0.874), 0.860(95%CI 0.677-1.000), 0.880 (95%CI 0.690-1.000), respectively. The DeLong test showed a statistically significant difference between the AUC values of the fusion model and the clinical model (P < 0.05). DCA showed that the fusion model with the greatest net benefit when the threshold probability was around 0.5.The fusion model constructed based on bp-MRI radiomics features combined with clinical features provides an important reference for predicting the risk status of recurrence in operable cervical cancer. This study is a preliminary exploratory result, and further large-scale, multicenter studies are needed to validate.
Keywords: cervical cancer, Radiomics, Recurrence risk stratification, machine learning, predictive model
Received: 07 Sep 2024; Accepted: 28 Jan 2025.
Copyright: © 2025 Du, Chen and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xue Du, North Sichuan Medical College, Nanchong, China
Min Li, North Sichuan Medical College, Nanchong, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.